The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Exosome Technologies Market Research Report 2025

Global Exosome Technologies Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1691556

No of Pages : 91

Ask Your Query

Synopsis

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.

Global Exosome Technologies market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.

Key companies engaged in the Exosome Technologies industry include Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Evox Therapeutics, Exosome Diagnostics, Inc., ExonanoRNA LLC.,, Codiak BioSciences and Esperite Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Exosome Technologies were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Exosome Technologies market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Exosome Technologies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Aegle Therapeutics
  •     Anjarium Biosciences
  •     Aruna Biomedical
  •     Carmine Therapeutics
  •     Evox Therapeutics
  •     Exosome Diagnostics, Inc.
  •     ExonanoRNA LLC.,
  •     Codiak BioSciences
  •     Esperite Group
  •     Tavec Pharmaceuticals

Segment by Type

  •     Transmission Electron Microscopy
  •     Nanoparticle Tracking Analysis
  •     Western Blot Molecular Marker Detection

Segment by Application

  •     Healthcare Providers
  •     Pharmaceutical & Biotechnology Companies
  •     Others

By Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Exosome Technologies report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

 

1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Exosome Technologies Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Transmission Electron Microscopy
        1.2.3 Nanoparticle Tracking Analysis
        1.2.4 Western Blot Molecular Marker Detection
    1.3 Market by Application
        1.3.1 Global Exosome Technologies Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Healthcare Providers
        1.3.3 Pharmaceutical & Biotechnology Companies
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Exosome Technologies Market Perspective (2018-2029)
    2.2 Exosome Technologies Growth Trends by Region
        2.2.1 Global Exosome Technologies Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Exosome Technologies Historic Market Size by Region (2018-2023)
        2.2.3 Exosome Technologies Forecasted Market Size by Region (2024-2029)
    2.3 Exosome Technologies Market Dynamics
        2.3.1 Exosome Technologies Industry Trends
        2.3.2 Exosome Technologies Market Drivers
        2.3.3 Exosome Technologies Market Challenges
        2.3.4 Exosome Technologies Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Exosome Technologies Players by Revenue
        3.1.1 Global Top Exosome Technologies Players by Revenue (2018-2023)
        3.1.2 Global Exosome Technologies Revenue Market Share by Players (2018-2023)
    3.2 Global Exosome Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Exosome Technologies Revenue
    3.4 Global Exosome Technologies Market Concentration Ratio
        3.4.1 Global Exosome Technologies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Exosome Technologies Revenue in 2022
    3.5 Exosome Technologies Key Players Head office and Area Served
    3.6 Key Players Exosome Technologies Product Solution and Service
    3.7 Date of Enter into Exosome Technologies Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Exosome Technologies Breakdown Data by Type
    4.1 Global Exosome Technologies Historic Market Size by Type (2018-2023)
    4.2 Global Exosome Technologies Forecasted Market Size by Type (2024-2029)

 5 Exosome Technologies Breakdown Data by Application
    5.1 Global Exosome Technologies Historic Market Size by Application (2018-2023)
    5.2 Global Exosome Technologies Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Exosome Technologies Market Size (2018-2029)
    6.2 North America Exosome Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Exosome Technologies Market Size by Country (2018-2023)
    6.4 North America Exosome Technologies Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Exosome Technologies Market Size (2018-2029)
    7.2 Europe Exosome Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Exosome Technologies Market Size by Country (2018-2023)
    7.4 Europe Exosome Technologies Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Exosome Technologies Market Size (2018-2029)
    8.2 Asia-Pacific Exosome Technologies Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Exosome Technologies Market Size by Region (2018-2023)
    8.4 Asia-Pacific Exosome Technologies Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Exosome Technologies Market Size (2018-2029)
    9.2 Latin America Exosome Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Exosome Technologies Market Size by Country (2018-2023)
    9.4 Latin America Exosome Technologies Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Exosome Technologies Market Size (2018-2029)
    10.2 Middle East & Africa Exosome Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Exosome Technologies Market Size by Country (2018-2023)
    10.4 Middle East & Africa Exosome Technologies Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Aegle Therapeutics
        11.1.1 Aegle Therapeutics Company Detail
        11.1.2 Aegle Therapeutics Business Overview
        11.1.3 Aegle Therapeutics Exosome Technologies Introduction
        11.1.4 Aegle Therapeutics Revenue in Exosome Technologies Business (2018-2023)
        11.1.5 Aegle Therapeutics Recent Development
    11.2 Anjarium Biosciences
        11.2.1 Anjarium Biosciences Company Detail
        11.2.2 Anjarium Biosciences Business Overview
        11.2.3 Anjarium Biosciences Exosome Technologies Introduction
        11.2.4 Anjarium Biosciences Revenue in Exosome Technologies Business (2018-2023)
        11.2.5 Anjarium Biosciences Recent Development
    11.3 Aruna Biomedical
        11.3.1 Aruna Biomedical Company Detail
        11.3.2 Aruna Biomedical Business Overview
        11.3.3 Aruna Biomedical Exosome Technologies Introduction
        11.3.4 Aruna Biomedical Revenue in Exosome Technologies Business (2018-2023)
        11.3.5 Aruna Biomedical Recent Development
    11.4 Carmine Therapeutics
        11.4.1 Carmine Therapeutics Company Detail
        11.4.2 Carmine Therapeutics Business Overview
        11.4.3 Carmine Therapeutics Exosome Technologies Introduction
        11.4.4 Carmine Therapeutics Revenue in Exosome Technologies Business (2018-2023)
        11.4.5 Carmine Therapeutics Recent Development
    11.5 Evox Therapeutics
        11.5.1 Evox Therapeutics Company Detail
        11.5.2 Evox Therapeutics Business Overview
        11.5.3 Evox Therapeutics Exosome Technologies Introduction
        11.5.4 Evox Therapeutics Revenue in Exosome Technologies Business (2018-2023)
        11.5.5 Evox Therapeutics Recent Development
    11.6 Exosome Diagnostics, Inc.
        11.6.1 Exosome Diagnostics, Inc. Company Detail
        11.6.2 Exosome Diagnostics, Inc. Business Overview
        11.6.3 Exosome Diagnostics, Inc. Exosome Technologies Introduction
        11.6.4 Exosome Diagnostics, Inc. Revenue in Exosome Technologies Business (2018-2023)
        11.6.5 Exosome Diagnostics, Inc. Recent Development
    11.7 ExonanoRNA LLC.,
        11.7.1 ExonanoRNA LLC., Company Detail
        11.7.2 ExonanoRNA LLC., Business Overview
        11.7.3 ExonanoRNA LLC., Exosome Technologies Introduction
        11.7.4 ExonanoRNA LLC., Revenue in Exosome Technologies Business (2018-2023)
        11.7.5 ExonanoRNA LLC., Recent Development
    11.8 Codiak BioSciences
        11.8.1 Codiak BioSciences Company Detail
        11.8.2 Codiak BioSciences Business Overview
        11.8.3 Codiak BioSciences Exosome Technologies Introduction
        11.8.4 Codiak BioSciences Revenue in Exosome Technologies Business (2018-2023)
        11.8.5 Codiak BioSciences Recent Development
    11.9 Esperite Group
        11.9.1 Esperite Group Company Detail
        11.9.2 Esperite Group Business Overview
        11.9.3 Esperite Group Exosome Technologies Introduction
        11.9.4 Esperite Group Revenue in Exosome Technologies Business (2018-2023)
        11.9.5 Esperite Group Recent Development
    11.10 Tavec Pharmaceuticals
        11.10.1 Tavec Pharmaceuticals Company Detail
        11.10.2 Tavec Pharmaceuticals Business Overview
        11.10.3 Tavec Pharmaceuticals Exosome Technologies Introduction
        11.10.4 Tavec Pharmaceuticals Revenue in Exosome Technologies Business (2018-2023)
        11.10.5 Tavec Pharmaceuticals Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock